ACTOplus met is marketed by Takeda Pharmaceuticals USA and used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes.
According to IMS sales data, ACTOplus met had annual sales of approximately $413m in the US as of 30 June 2012.
Teva Pharmaceutical Industries produces and markets generic drugs as well as specialty pharmaceuticals and active pharmaceutical ingredients.